AEM-28001-45291
4 vaccinations
9 coded responses
44 check-ins
9 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 376 / TN
- Registered
- 2021-02-09
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-09
Registered in v-safe
-
2021-02-09
Dose 1 — Pfizer-BioNTech
-
2021-02-09
Survey response — day 0, dose 1MedDRA: No adverse event — Feeling: GoodFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-10
Survey response — days 1–6 daily, dose 1MedDRA: Adverse reaction — Feeling: Good · Fever · Chills, Fatigue or tiredness, NauseaFree text: This all occurred last evening. Didnt last long.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-11
- 2021-02-12
- 2021-02-13
- 2021-02-14
- 2021-02-15
- 2021-02-16
-
2021-02-23
Survey response — day 14, dose 1MedDRA: Rash — Feeling: GoodFree text: Small rash developed a week after first vaccine in two locations. No itching or pain. Has not gone away and has gotten slightly larger.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-02
Dose 2 — Pfizer-BioNTech
-
2021-03-02
Health check-in — day 0, dose 2Feeling: Fair · Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-03
Survey response — days 1–6 daily, dose 2MedDRA: Adverse reaction — Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesFree text: Felt a bit better as the day went on.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-04
Health check-in — days 1–6 daily, dose 2Feeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
-
2021-03-05
Health check-in — days 1–6 daily, dose 2Feeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
-
2021-03-06
Health check-in — days 1–6 daily, dose 2Feeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
-
2021-03-07
Health check-in — days 1–6 daily, dose 2Feeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
-
2021-03-08
Survey response — days 1–6 daily, dose 2MedDRA: Rash — Feeling: Good · Rash, not including the immediate area around the injection siteFree text: Second rash appeared yesterday - different spot- different appearance.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-09
Survey response — day 7, dose 2MedDRA: Rash — Feeling: Good · Rash, not including the immediate area around the injection siteFree text: 2 rashes - seem to be lessening a bit.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-16
- 2021-03-23
- 2021-03-30
- 2021-04-06
- 2021-04-13
-
2021-06-01
Survey response — 3 months, dose 2MedDRA: Bronchitis, Cough, Nasopharyngitis, Oropharyngeal pain — Feeling: Good · Be unable to do your normal daily activitiesFree text: 10 day long cold symptoms, sore throat, coughing, bronchitis. No fever. Good appetite, no smell or taste issues. Did not get covid test.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-09-29
Dose 3 — Pfizer-BioNTech
- 2021-10-01
- 2021-10-03
- 2021-10-04
- 2021-10-05
- 2021-10-06
- 2021-10-13
- 2021-10-20
- 2021-10-27
- 2021-11-03
-
2021-11-12
Survey response — day 42, dose 3MedDRA: Nasopharyngitis, Oropharyngeal pain — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Headcold and sore throatMedDRA releases: 2024-11 · check-in free text available
- 2021-12-29
- 2022-03-30
-
2022-04-28
Dose 4 — Moderna
- 2022-05-05
- 2022-05-13
- 2022-05-19
- 2022-05-27
-
2022-06-03
Survey response — day 35, dose 4MedDRA: Fatigue, Nasopharyngitis, Oropharyngeal pain — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Sore throat, tired. Head cold starting?MedDRA releases: 2024-11 · check-in free text available
- 2022-06-09
- 2022-07-28
- 2022-10-27
- 2023-04-28
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-09 | Pfizer-BioNTech | |
| 2 | 2021-03-02 | Pfizer-BioNTech | |
| 3 | 2021-09-29 | Pfizer-BioNTech | No |
| 4 | 2022-04-28 | Moderna | No |
Free text
Release 3 — day 0, dose 1
Systemic reaction (other): No
Release 4 — days 1–6 daily, dose 1
Systemic reaction (other): This all occurred last evening. Didnt last long.
Release 4 — day 14, dose 1
Symptoms: Small rash developed a week after first vaccine in two locations. No itching or pain. Has not gone away and has gotten slightly larger.
Release 5 — days 1–6 daily, dose 2
Systemic reaction (other): Felt a bit better as the day went on.
Systemic reaction (other): Second rash appeared yesterday - different spot- different appearance.
Release 5 — day 7, dose 2
Systemic reaction (other): 2 rashes - seem to be lessening a bit.
Release 8 — 3 months, dose 2
Symptoms: 10 day long cold symptoms, sore throat, coughing, bronchitis. No fever. Good appetite, no smell or taste issues. Did not get covid test.
Release 10 — day 42, dose 3
Symptoms: Headcold and sore throat
Release 11 — day 35, dose 4
Symptoms: Sore throat, tired. Head cold starting?
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Bronchitis | ✓ | ✓ | ✓ |
| SD | Cough | ✓ | ✓ | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Rash | ✓ | ✓ | ✓ |
| SRO | Adverse reaction | ✓ | ✓ | ✓ |
| SRO | No adverse event | ✓ | ✓ | ✓ |
| SRO | Rash | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release